FY21 NSTM-Shonan Budget Detail And FY21 MRP Start
- 아래 FY20 그림 보면 NSTM actual 은 28억원
- NSTM-SHonan:: Correct amount is 0.144 OKY (0.012 OKY for Yan/Jaewon/Tim-san * 12 M) ($130,909). → At May 19 BDIB, it was decided that 75% of Fundamental budget should be allocated to TSHO Unit/Labs considering that Lab work in Shonan will be re-start starting Jun/Jul. So, NS-TM Shonan (Yan/Jaewon/Tim-san) can use 0.144 * 0.75 = 0.108 OKY ($130,909*0.75=$98,182)
| Fundamental | NSTM | TREM | Indirect | Fundamental budget for NSTM Shonan based on headcount | Ling | Planning | 144,000 | $144,000 |
|---|
FY20
- NSTM
- Fy20 plan은 32억원 (excluding co research)
| FY20 Budget Total (USD) | FY20 Actual Total (USD) | Balance (USD) | |
|---|---|---|---|
| ENSI | 2,412,401 | 1,089,146 | 1,323,256 |
| NS-TM | 3,078,218 | 1,349,482 | 1,728,736 |
| CPU Bio | 4,634,465 | 4,253,079 | 381,386 |
| TCAL chem | 4,320,213 | 3,174,086 | 1,146,127 |
NSTM-Shonan budget
- :$32,727 (= 3,600 k-yen= (안써서 깎였는지) 25% of the original total FY20 budget)
- (이게 September로 전부 잡혀있었는데, 20201124현재 no spending)
- MC1 in vitro study는 $11,000 (JPN One million yen)
| 시점 | 연 사용계획 | 누적사용 (actual) | Balance | 애조월별 사용계획 | 실사용 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| k-yen | $ | k-yen | $ | k-yen | $ | k-yen | $ | k-yen | $ | |
| Before 202008 | 아마 아래+25% | |||||||||
| 202008 | 3,600 | 32,727 | 0 | 0 | 3,600 | 32,727 | 9 월에 3,600 | 9 월에 32,727 | 0 | 0 |
| 202104 | 1800 (due to MC1 transfer of 1800 to PhreT) | 16364 | 75 | 685.91 | 1725 | 15,678 | 1800 | 16364 | 2 월에 30 | 2 월에 274 |
FY19 actual spend vs. the amended FY20 plan (after Q1-Q2 program-specific budget allocation), as of August 2020
(assuming 12 OKY buy-up will be additionally funded in FY20)
Stacked-bar legend: Fundamental budget; Program-specific budget; Other April actual; Material (April-June actual spend); License (fundamental commitment); Consignment (fundamental commitment); Ordered (submitted as buy-up); Ordered. Uncommitted vs. Committed brackets group categories. Annotations: Q3-Q4 priority program budget 2.46; HDO budget 3.5; Uncommitted not allocated 1.29. Y-axis is oku-yen, range 0.0 to 14.0.
Visible numeric labels per FY column on the bar chart:
- TCAL chem: FY19 act 2.94, FY20 BU(+) 4.61 (1.40 / 2.01), FY20 act 2.58
- CPU Bio: FY19 act 4.43, FY20 BU(+) 4.98 (3.66), FY20 act 2.66
- ENSI: FY19 act 1.11, FY20 BU(+) 2.53 (1.52 / 0.7), FY20 act 0.37
- ANCEL: FY19 act 12.06 11.63, FY20 BU(+) 0.25 1.47 1.11 1.26 4.78, FY20 act 4.80
- OEU Bio: FY19 act 0.75, FY20 BU(+) 1.15 (0.31), FY20 act 0.14
- ARNU Bio: FY19 act 2.66, FY20 BU(+) 1.01 (0.16), FY20 act 0.70
- EONU Bio: FY19 act 3.28, FY20 BU(+) 2.29 (0.94), FY20 act 0.81
- NSRU Bio: FY19 act 1.87, FY20 BU(+) 0.38, FY20 act 0.31
- PHRET: FY19 act 1.71, FY20 BU(+) 1.47 (0.49), FY20 act 0.29
- NS-TM: FY19 act 2.80, FY20 BU(+) 3.21 (0.39 / 1.45), FY20 act 0.65
- PSP: FY19 act 0.07, FY20 BU(+) 0.05, FY20 act 0.00
- Consignment: FY19 act 0.16, FY20 BU(+) 0.17 (0.01), FY20 act 1.29
“Not Including DDS budget.”
FY20 act: April-July actual spend including material, license and consignment
FY21
- NSTM
- FMCL (Allocated by employee #, Wet lab work)
- Consignment
- is captured in project budgets for FY21
- Co-Research
- is separate
- NSTM
- (20210518 Koujirou’s draft) total: 306,300,000 JPN
- NSTM-Shonan: at least 98,182 USD (0.11 OKY)/year (20210422 Maekawa Koujirou) → SEE Below
- (20210518 Koujirou’s draft) total: 306,300,000 JPN
| NSTM-Shonan FMCL budget SAP | oky | $ | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| budget | actual | balance | budget | actual | balance | |||||
| 2021 | 5 | 0.11 | ||||||||
| 6 | 0.15 | Increased because Masato joined | ||||||||
| 7 | 0.15 | |||||||||
| 8 | 0.15 | |||||||||
| 9 | 0.15 | |||||||||
| 10 | 0.21 | this budget is being shared by 7 people: Yan, me, Masato-san, Tim, Lisa-san, Tsuyoshi-san, and Sou-san | ||||||||
| 11 | 0.21 | |||||||||
| 12 | 0.21 | 0.01 | 0.20 | 198,450 (이건 PARKIN gt BINDING ASSAY 포함된 것임) | 6,499 | 191,951 | ||||
| 2022 | 1 | 0.21 | 0.03 | 0.18 | 198,450 | 30,125 | 168,325 | |||
FY21 D. KPI-linked projects and tentative budget
| Category | Project | Tentative Budget size (Mainly bio/TM budget) |
|---|---|---|
| HDO project | HTT MAPT SNCA OMA1 DMPK Other new programs | 3.0 OKY |
| GT project | FXN GT GBA PD GT NG mHTT GT Parkin GT StrideBio #2  Heidelberg-related | 1.5 OKY |
| KPI-linked Small Molecule project (E to CS) | IP6Ks Inhibitor | 0.6 OKY |
| HTT splicing Modulator | 0.9 OKY | |
| MAP4K4-Ferro Inhibitor | 0.9 OKY | |
| G4 Oral OX2R Agonist BU | 0.6 OKY | |
| KPI-linked Small Molecule project (G to PE) | PKR Inhibitor | 0.5 OKY |
| NLRP3 Inhibitor | 0.5 OKY |
- MYC (Mid-Year Commitment)
- 당해년도의 HALF-way through assessment
-
MRP
- Questions
- Can I use NS-TM Shonan FY20 budet?
- Pocket: project? Kamiguchi-san’s team? Specific budget?
FY21 MRP
- Fundamental, Material, Consignment, License (FMCL budget)
\takeda\tpc\groups\folder066\T-Research\CNS_DDU\Section_Folders\Associate_Directors\CNS_DDU_common\Finance\FY21-23 MRP策定\Material Consignment License\NS DDU budget
- Definition of fundamental license is licenses that are utilized for multiple projects across boundaries of Unit/Labs. Licenses that are related to single specific project only should NOT be listed as fundamental license. Please be sure to list ongoing co-research-related committed cost (cost that Takeda must bear outside co-research cost paid to the partner as Takeda’s obligation following its terms of agreement) as Fundamental budget Regarding KPI-linked project budget including Biology/TM budget/Aptuit FTE cost, please list in each “Project team” file, NOT in each Unit/Labs file consulting with relevant Unit/Labs which are responsible for implementation
- Direct cost:
\takeda\tpc\groups\folder066\T-Research\CNS_DDU\Section_Folders\Associate_Directors\CNS_DDU_common\Finance\FY21-23 MRP策定\MRP\Direct cost
- If Direct cost exists, please update the relevant file.
- CAPEX (TSHO only) 下記にある末尾に（部門名）と記載のあるファイルを複製し、部門名を付けて保存の上、記入をお願いします。 \takeda\tpc\groups\folder066\T-Research\CNS_DDU\Section_Folders\Associate_Directors\CNS_DDU_common\Finance\FY21-23 MRP策定\M
Uncertain Spans
| location | transcription | uncertainty |
|---|---|---|
| Top context paragraph | 안써서 깎였는지 | The Korean parenthetical reads ambiguously between 안써서 깎였는지 and 안써서 까였는지; the surrounding clause about the original FY20 budget supports the first reading. |
| FY19/FY20 bar-chart legend numbers | per-column numeric labels | Several inline numbers (e.g. 1.52 0.7, 0.31, 0.16, 1.45 0.65) sit very close together on the bar chart; the values reflect the visible OCR but are bunched and may need recheck against the underlying spreadsheet. |
| NSTM-Shonan FMCL budget SAP | shared-7-people annotation row span | The “this budget is being shared by 7 people” cell visually spans rows 10–12 of 2021 in the source but is rendered here as a single rowspan against month 10 because the row separators are not consistently inked across all three rows. |
| FY21 MRP CAPEX line | trailing path | The CAPEX path ends mid-token at M near the photo edge; only the visible prefix is transcribed here. |